|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Restricted cash | |||||||||||
| Property and equipment, net | |||||||||||
| Right of use asset | |||||||||||
| Other assets, noncurrent | |||||||||||
| Total assets | |||||||||||
| Liabilities and stockholders' equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | |||||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Operating lease liability, current | |||||||||||
| Total current liabilities | |||||||||||
| Operating lease liability, noncurrent | |||||||||||
| Preferred stock tranche liability | |||||||||||
| Anti-dilution liability | |||||||||||
| Total liabilities | |||||||||||
| Redeemable convertible preferred stock | |||||||||||
| Stockholders' equity: | |||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized at December 31, 2024 and March 31, 2025; 44,861,763 and 44,956,238 shares issued and outstanding at December 31, 2024 and March 31, 2025, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders' equity |
Loading...
